Publications by authors named "Jan van der Weide"

Claim this Profile
D
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP3A4 and CYP1A2 and antipsychotics.
Lianne Beunk, Marga Nijenhuis, Bianca Soree, Nienke J de Boer-Veger, Anne-Marie Buunk, Jan van der Weide

Eur J Hum Genet· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dutch pharmacogenetics working group guideline for the gene-drug interaction of ABCG2, HLA-B and Allopurinol, and MTHFR, folic acid and methotrexate.
Karel H van der Pol, Marga Nijenhuis, Bianca Soree, Nienke J de Boer-Veger, Anne Marie Buunk, Jan van der Weide

Eur J Hum Genet· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dutch pharmacogenetics working group (DPWG) guideline for the gene-drug interaction of CYP2D6 and COMT with atomoxetine and methylphenidate.
Marga Nijenhuis, Bianca Soree, Wafa O M Jama, Nienke J de Boer-Veger, Anne Marie Buunk, Jan van der Weide

Eur J Hum Genet· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dutch pharmacogenetics working group (DPWG) guideline for the gene-drug interaction between UGT1A1 and irinotecan.
Emma C Hulshof, Maarten J Deenen, Marga Nijenhuis, Bianca Soree, Nienke J de Boer-Veger, Jan van der Weide

Eur J Hum Genet· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between UGT1A1 and irinotecan.
Emma C Hulshof, Maarten J Deenen, Marga Nijenhuis, Bianca Soree, Nienke J de Boer-Veger, Jan van der Weide

Eur J Hum Genet· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6 and opioids (codeine, tramadol and oxycodone).
Maja Matic, Marga Nijenhuis, Bianca Soree, Nienke J de Boer-Veger, Anne-Marie Buunk, Jan van der Weide

Eur J Hum Genet· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6 and opioids (codeine, tramadol and oxycodone).
Maja Matic, Marga Nijenhuis, Bianca Soree, Nienke J de Boer-Veger, Anne-Marie Buunk, Jan van der Weide

Eur J Hum Genet· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2C19 and CYP2D6 and SSRIs.
Jurriaan M J L Brouwer, Marga Nijenhuis, Bianca Soree, Henk-Jan Guchelaar, Jesse J Swen, Jan van der Weide

Eur J Hum Genet· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Drug Monitoring of Psychotropics as a Diagnostic Tool for CYP2D6 Poor Metabolizer Phenotype.
Soraya V Ganesh, Lianne Beunk, Bojan Nikolik, Jan van der Weide, Pierre M Bet

Ther Drug Monit· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HLA-DQB1 6672G>C (rs113332494) is associated with clozapine-induced neutropenia and agranulocytosis in individuals of European ancestry.
Bettina Konte, James T R Walters, Dan Rujescu, Sophie E Legge, Antonio F Pardiñas, Jan van der Weide, Karen van der Weide

Transl Psychiatry· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction of DPYD and fluoropyrimidines.
Carin A T C Lunenburg, Cathelijne H van der Wouden, Marga Nijenhuis, Mandy H Crommentuijn-van Rhenen, Nienke J de Boer-Veger, Jan van der Weide

Eur J Hum Genet· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenetic Information in Clinical Guidelines: The European Perspective.
Jesse J Swen, Marga Nijenhuis, Mandy van Rhenen, Nienke J de Boer-Veger, Anne-Marie Buunk, Jan van der Weide

Clin Pharmacol Ther· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accurate determination of the CYP2D6 (*1/*4)xN genotype by quantitative PCR.
Kirsten M Pondman, Ron H N van Schaik, Jan van der Weide

Drug Metab Pers Ther· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Influence of the CYP3A4*22 Polymorphism and CYP2D6 Polymorphisms on Serum Concentrations of Aripiprazole, Haloperidol, Pimozide, and Risperidone in Psychiatric Patients.
Karen van der Weide, Jan van der Weide

J Clin Psychopharmacol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The influence of the CYP3A4*22 polymorphism on serum concentration of quetiapine in psychiatric patients.
Karen van der Weide, Jan van der Weide

J Clin Psychopharmacol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The association between CYP2D6 genotype and switching antipsychotic medication to clozapine.
Jochem G Gregoor, Karen van der Weide, Jan van der Weide, Harold J G M van Megen, Antoine C G Egberts

Eur J Clin Pharmacol· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polymorphisms of the LEP, LEPR and HTR2C gene: obesity and BMI change in patients using antipsychotic medication in a naturalistic setting.
Jochem G Gregoor, Jan van der Weide, Harriët M Loovers, Harold J G M van Megen, Toine C G Egberts

Pharmacogenomics· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between LEP and LEPR gene polymorphisms and dyslipidemia in patients using atypical antipsychotic medication.
Jochem G Gregoor, Jan van der Weide, Harriet M Loovers, Harold J van Megen, Toine C Egberts

Psychiatr Genet· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined HTR2C-LEP genotype as a determinant of obesity in patients using antipsychotic medication.
Jochem G Gregoor, Hans Mulder, Dan Cohen, Harold J G M van Megen, Toine C G Egberts, Jan van der Weide

J Clin Psychopharmacol· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of CYP2D6 genotyping in psychiatry.
Harriët M Loovers, Jan van der Weide

Expert Opin Drug Metab Toxicol· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polymorphisms of the LEP- and LEPR gene and obesity in patients using antipsychotic medication.
Jochem G Gregoor, Jan van der Weide, Hans Mulder, Dan Cohen, Harold J G M van Megen

J Clin Psychopharmacol· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Semi-quantitative CYP2D6 gene doses in relation to metabolic ratios of psychotropics.
John W J Hinrichs, Harriët M Loovers, Bart Scholten, Jan van der Weide

Eur J Clin Pharmacol· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of CYP2D6 polymorphisms *9, *10, and *41 using ARMS-PCR and their allelic frequencies in 400 psychiatric patients.
John W J Hinrichs, Windy D Smallegoor, Erica H van Baalen-Benedek, Chris Welker, Jan van der Weide

Clin Chem Lab Med· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic drug monitoring of antidepressants and cytochrome p450 genotyping in general practice.
Jenny E Kootstra-Ros, Marga J M Van Weelden, John W J Hinrichs, Peter A G M De Smet, Jan van der Weide

J Clin Pharmacol· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The influence of cytochrome P450 pharmacogenetics on disposition of common antidepressant and antipsychotic medications.
Jan van der Weide, John W J Hinrichs

Clin Biochem Rev· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis